The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence and trajectory of disease- and treatment-related symptom burden in patients with multiple myeloma undergoing induction therapy.
R. Z. Orlowski
No relevant relationships to disclose
X. S. Wang
No relevant relationships to disclose
T. R. Mendoza
No relevant relationships to disclose
L. A. Williams
No relevant relationships to disclose
V. E. Johnson
No relevant relationships to disclose
J. Joy
No relevant relationships to disclose
V. Ilagan
No relevant relationships to disclose
G. M. Mobley
No relevant relationships to disclose
P. Liu
No relevant relationships to disclose
K. R. Gilmore
No relevant relationships to disclose
C. S. Cleeland
No relevant relationships to disclose